Programme congrès TAO CTM Meeting
2022

Jeudi 15 décembre 2022

Les horaires sont exprimés en heure normale d’Europe centrale (UTC+1)

TimingTitle suggestions Speaker suggestions
9:30-9:45 AMIntroduction / Meeting opening Florian Scotté, Villejuif
9:45-10:00 AMOPENING SESSION / CANCER CARE, GO TO THE FUTURE Maryam Lustberg, USA
10:00-11:00 AMPLENARY SESSION
LONG TERM SAFETY

Management of AYA in the long term (adolescent young adults).

CARTcells (and B cells aplasia).

Immunotherapy long term safety.

Nathalie Gaspar, Villejuif



Paolo Bossi, Brescia
11:00-11:45 AM« MEET THE EXPERTS » SESSIONS

Triple negative: pathway’s problematics.
Non anemic iron deficiency in cancer patients.
Severe diarrhea and targeted therapies: management.
NEW


Mario Dicato, Luxembourg


11:45-12:00 AM Break
12:00-1:00 PMPLENARY SESSION
NEW DRUGS AND SAFETY / TUMOR LOCALIZATION

Lung.

GI (digestive).

Hematology.

Denis Moro-Sibilot, Grenoble

Jean-Philippe Metges, Brest

Pierre Sesques, Lyon
1:00-2:00 PMLunch
2:00-3:00 PMPLENARY SESSION
GI SAFETY

Taste and PhotoBioModulation.

The vicious circle of mucositis.

Nutrition: modern screening and management (prevention and treatment) of denutrition.

Joël Epstein, Duarte USA

Emmanuelle Vigarios, Toulouse

Jeffrey Crawford, USA

3:00-3:30 PMSYMPOSIUM
3:30-3:45 PM Break
3:45-4:15 PMPLENARY SESSION
SKIN: FROM INNOVATIVE THERAPIES TO TOXICITIES

Innovative therapies in melanoma: efficacy and safety.

Skin toxicities of innovative anticancer therapies.

Vincent Sibaud, Toulouse

Mario Lacouture, USA

4:15-5:15 PMPLENARY SESSION
DIGITAL HEALTH, NEXT STEPS

Patient’s experience.

Patient-reported symptom monitoring and management

Guidelines (ESMO).

Etienne Minvielle, Paris

Kathi Mooney, USA

Massimo Di Maio, Naples
5:15-6:45 PMYOUNG PHYSICIAN AWARD JEAN KLASTERSKY
Presentation of the 6 first clinical cases (6 x 15 min)

Vendredi 16 décembre 2022

TimingTitle suggestions Speaker suggestions
8:45-9:30 AMLONG TERM SAFETY 2

Rare immune-related adverse events

Targeted therapies in the long course


Olivier Lambotte, Le Kremlin-Bicêtre

Jaafar Bennouna, Suresnes

9:30-10:15 AMCARDIO-ONCOLOGY:
MANAGING CARDIOVASCULAR TOXICITY

Screening before treating, monitoring during and after treating.

« Venous Thromboembolism in oncology patients : managing anticancer toxicity and anticoagulation therapy »

Myocarditis and innovative therapies.



Stephane Edhery, Paris

Ismail Elalamy, Paris


Joe-Elie Salem, Paris
10:15-10:45 AMSYMPOSIUM
10:45-11:00 AMBreak
11:00-12:00 PMPLENARY SESSION
NEW DRUGS AND SAFETY / TUMOR LOCALIZATION

Breast.

GU (Urology).

Gynecology.



Barbara Pistilli, Villejuif

Yann Vano, Paris

Thibault de la Motte Rouge , Rennes


12:00-1:00 PMLunch
1:00-1:30 PMSYMPOSIUM
1:30-2:30 PMPLENARY SESSION
SURVIVORSHIP: FROM PATIENTS TO CAREGIVERS

Patients & patients relatives interviews.



Elodie Vauleon, Rennes
Maryam Lustberg, USA

2:30-3:15 PMPLENARY SESSION
UNSCHEDULED PATHWAYS

ICU and cancer patients.
– Screening before and during treatment.
– Shared decision making.
– Management of new toxicities.

Emergencies and cancer: Experience Italy

Emergencies:
Panel discussion



Naïke Bigé, Villejuif




Gianmauro Numico, Italy. TBC
3:15-3:30 PMBreak
3:30-4:15 PMPLENARY SESSION
CINV LECTURE

New Guidelines

One day prophylaxis: how to deal with?
Chair: Richard Gralla, USA


Jørn Herrstedt, Denmark

Richard Gralla, USA

4:15-4:45 PMPLENARY SESSION
LECTURE: COMMUNICATION APPROACHES FOR CHALLENGING SITUATIONS
Judith Nelson, USA
4:45-5:00 PMYOUNG PHYSICIAN AWARD JEAN KLASTERSKY
Award ceremony
5:00-5:45 PMConclusion Florian Scotté, Villejuif